Literature DB >> 20603349

Legionellosis: Why should I test and report?

Thomas J Marrie1, Jason R Garay, Erica Weir.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20603349      PMCID： PMC2950186          DOI： 10.1503/cmaj.082030

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  20 in total

1.  Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system.

Authors:  Núria Fernández-Sabé; Beatriz Rosón; Jordi Carratalà; Jordi Dorca; Frederic Manresa; Francesc Gudiol
Journal:  Clin Infect Dis       Date:  2003-07-28       Impact factor: 9.079

2.  Communitywide outbreak of Legionnaires' disease associated with a grocery store mist machine.

Authors:  F J Mahoney; C W Hoge; T A Farley; J M Barbaree; R F Breiman; R F Benson; L M McFarland
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 4.  Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint.

Authors:  G W Waterer; V S Baselski; R G Wunderink
Journal:  Am J Med       Date:  2001-01       Impact factor: 4.965

5.  Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

Authors:  J F Plouffe; T M File; R F Breiman; B A Hackman; S J Salstrom; B J Marston; B S Fields
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

6.  Legionnaires' disease outbreak at an Atlanta, Georgia, Country Club: evidence for spread from an evaporative condenser.

Authors:  L G Cordes; D W Fraser; P Skaliy; C A Perlino; W R Elsea; G F Mallison; P S Hayes
Journal:  Am J Epidemiol       Date:  1980-04       Impact factor: 4.897

7.  Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.

Authors:  Rosa Maria Blázquez Garrido; Francisco Javier Espinosa Parra; Loreto Alemany Francés; Rosa Maria Ramos Guevara; Juan Miguel Sánchez-Nieto; Manuel Segovia Hernández; José Antonio Serrano Martínez; Faustino Herrero Huerta
Journal:  Clin Infect Dis       Date:  2005-02-17       Impact factor: 9.079

8.  Increased rainfall is associated with increased risk for legionellosis.

Authors:  L A Hicks; C E Rose; B S Fields; M L Drees; J P Engel; P R Jenkins; B S Rouse; D Blythe; A P Khalifah; D R Feikin; C G Whitney
Journal:  Epidemiol Infect       Date:  2006-11-23       Impact factor: 2.451

9.  Legionnaires' disease - Results of a multicentre Canadian study.

Authors:  Thomas J Marrie; Emidio De Carolis; Victor L Yu; Janet Stout
Journal:  Can J Infect Dis       Date:  2003-05

10.  A community hospital outbreak of legionellosis. Transmission by potable hot water.

Authors:  J P Hanrahan; D L Morse; V B Scharf; J G Debbie; G P Schmid; R M McKinney; M Shayegani
Journal:  Am J Epidemiol       Date:  1987-04       Impact factor: 4.897
View more
  2 in total

1.  Amyloid hybrid membranes for bacterial & genetic material removal from water and their anti-biofouling properties.

Authors:  Archana Palika; Akram Rahimi; Sreenath Bolisetty; Stephan Handschin; Peter Fischer; Raffaele Mezzenga
Journal:  Nanoscale Adv       Date:  2020-09-11

2.  Genomic characterization of a large outbreak of Legionella pneumophila serogroup 1 strains in Quebec City, 2012.

Authors:  Simon Lévesque; Pier-Luc Plante; Nilmini Mendis; Philippe Cantin; Geneviève Marchand; Hugues Charest; Frédéric Raymond; Caroline Huot; Isabelle Goupil-Sormany; François Desbiens; Sébastien P Faucher; Jacques Corbeil; Cécile Tremblay
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.